Biocryst Pharmaceuticals buy Evercore ISI
Start price
20.04.23
/
50%
€6.67
Target price
20.04.24
€9.11
Performance (%)
-38.50%
End price
21.04.24
€4.10
Summary
This prediction ended on 21.04.24 with a price of €4.10. The BUY prediction by Evercore_ISI for Biocryst Pharmaceuticals performed very badly with a performance of -38.50%. Evercore_ISI has a follow-up prediction for Biocryst Pharmaceuticals where he still thinks Biocryst Pharmaceuticals is a Buy. Evercore_ISI has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Biocryst Pharmaceuticals | -1.073% | -1.073% | -10.211% |
| iShares Core DAX® | 0.734% | 1.458% | 17.980% |
| iShares Nasdaq 100 | -2.686% | -0.146% | 3.810% |
| iShares Nikkei 225® | -2.261% | -2.729% | 11.679% |
| iShares S&P 500 | -1.346% | 0.467% | 1.970% |
Comments by Evercore_ISI for this prediction
In the thread Biocryst Pharmaceuticals diskutieren
BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX) had its price target lowered by analysts at Evercore ISI from $13.00 to $10.00. They now have an "outperform" rating on the stock.
Ratings data for BCRX provided by MarketBeat
In the thread Trading Biocryst Pharmaceuticals
Die von Evercore_ISI gewählte maximale Laufzeit wurde überschritten
Current prediction by Evercore_ISI for Biocryst Pharmaceuticals
Biocryst Pharmaceuticals
Start price
Target price
Perf. (%)
€7.73
13.01.25
13.01.25
€11.76
13.01.26
13.01.26
-16.46%
12.12.25
12.12.25
